InvestorsHub Logo
Followers 4
Posts 1807
Boards Moderated 0
Alias Born 08/07/2006

Re: enemem post# 35664

Wednesday, 02/02/2011 1:43:39 PM

Wednesday, February 02, 2011 1:43:39 PM

Post# of 50600
Perhaps, what's really needed is an overhaul of the FDA process? The barriers to drug development are high cost and liability, which is typically shouldered by the U.S. population in the form of high drug prices before going generic. If the FDA could be encouraged to streamline the process, perhaps Cortex could get something going?
MF4
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RSPI News